New York, NY -- (SBWIRE) -- 01/30/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Plug Power Inc(NASDAQ:PLUG), Cereplast Inc(OTCMKTS:CERP), Delcath Systems, Inc.(NASDAQ:DCTH), Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)
Plug Power Inc(NASDAQ:PLUG) managed to keep its gain at 10.37% on above-normal volume of 29.69M shares. The stock settled at $2.97, after floating in a range of $2.56 - 3.21. Its latest price has reached market capitalization of $347.46M. Its 52-week range has been $0.12 - 4.90. Plug Power Inc. (Plug Power), is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road (forklift or material handling) market.
Should Investors Trade PLUG Now? Don’t Miss out a Special Trend Analysis
Cereplast Inc(OTCMKTS:CERP) trading on a volume of 18.70M shares, higher than its standard daily volume. Shares have been closed at $0.0045. Over the last twelve months, the stock has lost -87.14 % and faced a worst price of $ 0.00 Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
Is CERP a Solid Investment at These Levels? Read This Report for Details
Delcath Systems, Inc.(NASDAQ:DCTH) is up at $0.355 on above- normal volume of 11.36M shares during the last trading day. The stock has its 12-month range $ 0.22 - 2.19. Its Intraday range is $ 0.35 - 0.38. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology.
How Should Investors Trade DCTH Now? Don’t Miss out a Special Trend Analysis
In the last trading day, Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) is on high volume, trading at a volume of versus its average daily volume ratio 7.80M/1.17M shares. At $4.50 the stock has attained market capitalization of 273.71M. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology.
Will Investors Buy PGNX After Reading This News? Just Go Here And Find Out
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)